All of Medytox starts from R&D.

Pipeline

R&D is a starting point of drug development and commercialization and a locomotive in realizing continuous growth.

To keep our pride of R&D-based biopharmaceutical company, Medytox invests more than 15% of the total sales in R&D – Especially with Gwanggyo R&D Center, established with an one-stop system to conduct all drug development processes except for clinical trial, we are developing biopharmaceuticals that will pioneer the global market.
01
Candidate Selection
Securing
competitive technology /
substances
02
Nonclinical Study
Cell& animal
based efficacy
and toxicity test
03
Clinical study
Administration
dose selection &
therapeutic validation
04
Approval
Product Approval
Pipeline
Pipeline
Biopharmaceutical
Project
Indication
Discovery
Preclinical
Phase 1
Phase 2
Phase 3
Approval
Country
Neuronox®
Upperlimb Spasticity
Korea
Cerebral Palsy
Korea
Benign Essential
Eyelid Spasms.
Korea
Glabellar Line
Korea
Glabellar Line
China, Taiwan
Glabellar Line
Russia
Lateral Canthal Line
Korea
Blepharospasm
China
Cervical Dystonia
Korea
Benign Masseteric Hypertrophy
Korea
Overactive Bladder
Korea
Migraine
Korea
INNOTOX®
Glabellar Line
Korea
MT10109L Licensing out Allergan
Glabellar Line
US, Canada
Lateral Canthal Line
US, Canada
Coretox®
Glabellar Line
Korea
Upperlimb Spasticity
Korea
MT912
Macular Degeneration
-
MT925
Type 1 Diatetes
-
MT927
Immune Disorder
-
MT971
Inflammatory Bowel Disease
-
MT981
Cancers
-
바이오 의약품 그래프
Chemical Drug
Project
Indication
Discovery
Preclinical
Phase 1
Phase 2
Phase 3
Approval
Country
MT921
Lipolysis Injection
Korea
Synthetic Drugs Graph
Medical Device
Project
Indication
Discovery
Preclinical
Clinical Trial Stage
Approval
Country
Neuramis®
series *
Deep Facial Wrinkle
Korea
Neuramis®
Volume
Lidocaine
Mid Face Volume
Korea
Neuramis®
Volume
Lidocaine
Mid Face Volume
China
Neuramis®
Deep
Lidocaine
Nasolabial Folds
China
Atiere®
Deep Facial Wrinkle
Korea
Potenfill®
Temporary Penile
Enhancement
Korea
MT942
Post Surgical Adhesion
Prevention
Korea
MT941
Osteoarthritis
-
* Neuramis® Light Lidocaine, Neuramis® Lidocaine, Neuramis® Deep, Neuramis® Deep Lidocaine, Neuramis® Volume Lidocaine
Medical Device Graph
Health Supplements
Project
Indication
Discovery
Preclinical
Clinical Trial Stage
Approval
Country
MT961
Lipolysis
Korea
MT963
Hangover Cure
Korea
Health Supplements Graph